$178M Verdict Against Novartis Stands But Can't Be Tripled
By Dani Kass · September 30, 2022, 9:07 PM EDT
A California federal judge has upheld a jury's $177.8 million infringement verdict against Novartis but overturned the jury's finding that the infringement of a Daiichi Sankyo unit's patents was willful....
To view the full article, register now.